National Cancer Institute, IRCCS, Department of Medical Oncology

Milan

0 studies enrolling now · 1 studies all time

What they study most

NSCLC

Studies at this site

• Phase 2 Study of Poziotinib in Participants With NSCLC Having EGFR or HER2 Exon 20 Insertion Mutation — Stopped early